Journal: Cellular and Molecular Life Sciences: CMLS
Article Title: Role of lamin A/C on dendritic cell function in antiviral immunity
doi: 10.1007/s00018-024-05423-9
Figure Lengend Snippet: Lamin A/C deficiency in matured GM-CSF-BMDCs reduces CD4 T cell activation, proliferation and Th1 differentiation in vitro and in vivo. Flow cytometry was employed to assess the percentage of activated CD4 T cells, specifically gated on CD25 + or CD69 + cells; Th1-differentiated cells, specifically gated on IFNγ + cells; and proliferating CellTrace Violet + T cells. Maturation of GM-CSF-derived WT- and LysM-Lmna −/− -BMDCs was undertaken with ( A ) sonicated VACV extract, ( B ) Pam3CSK4, or ( C ) lipopolysaccharide (LPS), and, in all conditions, pulsed with OVA cognate OT-IIp. ( D ) WT- or Lmna −/− -BMDCs, matured with LPS and pulsed with the OVA 323–339 cognate OT-II peptide, were s.c. inoculated into CD45.1 OT-II recipient mice. Six days later, pLNs were extracted, and IFNγ-producing CD4 T cells were analyzed by flow cytometry. The data represent means ± SEM and are presented from a representative experiment out of 3 ( A and B , n = 3) or out of 4 ( C , n = 4) or out of 2 ( D , n = 4). Activation data were analyzed using One Way ANOVA and Bonferroni post-test, and proliferation and Th1 differentiation were assessed by unpaired Student’s t-test. Statistical significance was denoted by asterisks (* P < 0.05; ** P < 0.01; *** P < 0.001; ns, not significant). This schematic was created using Servier Medical Art templates, which are licensed under a Creative Commons Attribution CC BY 4.0 License; https://smart.servier.com
Article Snippet: Antibodies against: CD4 (Clone RM4-5, GK1.5) -v450, -APC and PE; CD25 (PC61.5) -APC; CD69 (H1.2F3)-FITC; CD28 (37.51); CD3 (145-2C11); CD45.1 (A20)-Pe-Cy7, -v450, -FITC; CD45.2 (104) -v450, -redFluor710; CD11b (M1/70)-v450; CD86 (GL-1) PE, PE-Cy7; IFNγ XMG1.2 FITC, -APC; Foxp3 (3G3)-FITC; MHC-II (I-A/I-E, M5/115.15.2)-APC; GR1 (RB6-8C5)-Biotin; CD80 (16-10A1)-Biotin, -VB711; B220 (RA3-6B2)-Biotin; F4/80 (BM8.1)-Biotin; CD11b (M1/70)-Biotin, -V450; CD19 (1D3)-Biotin; CD25 (PC61.5)-Biotin from Tonbo.
Techniques: Activation Assay, In Vitro, In Vivo, Flow Cytometry, Derivative Assay, Sonication